We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Initiates New Oncology Research Program to Conjugate Thorium-227 to Epratuzumab

News   Jan 29, 2013

 
Algeta Initiates New Oncology Research Program to Conjugate Thorium-227 to Epratuzumab
 
 
 

RELATED ARTICLES

Gut Protein Could Prevent Deadly Complication of Bone Marrow Transplant

News

Researchers have discovered that an antimicrobial protein found in the gut can stave off a common and highly lethal side effect of bone marrow transplants.

READ MORE

Drug Blocks Pancreatic Cancer Growth in Mice

News

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a new study.

READ MORE

Immunological Insight Offer Improvements in Salmonella Vaccines

News

A breakthrough in understanding which cells afford optimal protection against Salmonella infection is a critical step in developing a more effective and safe vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE